Efficacy of sequential annual vaccination with inactivated influenza virus vaccine
- PMID: 3337087
- DOI: 10.1093/oxfordjournals.aje.a114809
Efficacy of sequential annual vaccination with inactivated influenza virus vaccine
Abstract
Inactivated influenza virus vaccine efficacy after annual revaccination has been reported to be less than that after first vaccination in boarding school children. We prospectively examined the immunogenicity and efficacy of this vaccine in healthy 30- to 60-year-old volunteers in Houston, Texas, over two epidemic seasons (1983-1985) encompassing outbreaks due to influenza A (H3N2 and H1N1) and influenza B viruses. A placebo group that had never (or not in recent years) received inactivated influenza virus vaccine, a group that received the vaccine for the first time (first vac), and a group given two or more recent vaccinations (multivac) were evaluated in a double-blind fashion each year. Vaccination induced higher frequencies of rise in serum antibody titer to vaccine components in first vac than in multivac volunteers, but mean postvaccination titers were similar. Clinical and virologic evaluations of illnesses during both epidemics and of influenza infections diagnosed serologically over the epidemic seasons revealed no overall reduction in illness from that in the placebo group for either vaccine group; modest reductions in influenza infection-related illness that were significant only for the multivac group against A/H3N2-related illness (55%; p less than 0.04); reduction in moderate-to-severe lower respiratory and/or systemic illness due to influenza for multivac (73%, p less than 0.025) but not first vac (15%, p greater than 0.10) volunteers during the A/H3N2 epidemic; reduction in influenza virus shedding in the multivac (54%, p less than 0.05) but not the first vac (16%, p greater than 0.10) group when compared with the placebo group for both years; and overall 63-81% reductions in documented infections with each influenza virus for both vaccine groups with the exception of A/H1N1 for the first vac group (24%, p greater than 0.10) and type B for the multivac group (58%, p = 0.067). Vaccine efficacy was only modest in these studies, but in contrast to the earlier report in boarding school children, efficacy appeared to be somewhat greater after repeated annual vaccination than after first administration.
Similar articles
-
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?Pediatrics. 2006 Sep;118(3):e570-8. doi: 10.1542/peds.2006-0198. Pediatrics. 2006. PMID: 16950948 Clinical Trial.
-
Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.Pediatrics. 2006 Sep;118(3):e579-85. doi: 10.1542/peds.2006-0201. Pediatrics. 2006. PMID: 16950949 Clinical Trial.
-
Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial.J Med Virol. 2018 Jan;90(1):41-49. doi: 10.1002/jmv.24922. Epub 2017 Sep 25. J Med Virol. 2018. PMID: 28842994 Clinical Trial.
-
Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.Drugs R D. 2003;4(5):312-9. doi: 10.2165/00126839-200304050-00007. Drugs R D. 2003. PMID: 12952502 Review.
-
Repeated annual influenza vaccination and vaccine effectiveness: review of evidence.Expert Rev Vaccines. 2017 Jul;16(7):1-14. doi: 10.1080/14760584.2017.1334554. Epub 2017 Jun 9. Expert Rev Vaccines. 2017. PMID: 28562111 Review.
Cited by
-
Association of influenza vaccination and reduced risk of stroke hospitalization among the elderly: a population-based case-control study.Int J Environ Res Public Health. 2014 Apr 2;11(4):3639-49. doi: 10.3390/ijerph110403639. Int J Environ Res Public Health. 2014. PMID: 24699027 Free PMC article.
-
Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines.Aging health. 2008 Dec 1;4(6):603-613. doi: 10.2217/1745509X.4.6.603. Aging health. 2008. PMID: 20011611 Free PMC article.
-
Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011-2012 influenza vaccine season.Immun Ageing. 2013 Apr 22;10(1):14. doi: 10.1186/1742-4933-10-14. Immun Ageing. 2013. PMID: 23607926 Free PMC article.
-
Aging affects human B cell responses.J Clin Immunol. 2011 Jun;31(3):430-5. doi: 10.1007/s10875-010-9501-7. Epub 2011 Feb 12. J Clin Immunol. 2011. PMID: 21318330 Free PMC article. Review.
-
The Doctrine of Original Antigenic Sin: Separating Good From Evil.J Infect Dis. 2017 Jun 15;215(12):1782-1788. doi: 10.1093/infdis/jix173. J Infect Dis. 2017. PMID: 28398521 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical